These results suggest that the PI3K-AKT pathway is likely to be the switch for conversion among γδ T cell subsets, and the upregulation of VEGFR1 in γδ T cells may exert major drug resistance in breast cancer. This evidence concerns the gene FLT1 and breast carcinoma.